...
首页> 外文期刊>Future Science OA >Survival and glycemic control in patients with colorectal cancer and diabetes mellitus
【24h】

Survival and glycemic control in patients with colorectal cancer and diabetes mellitus

机译:大肠癌和糖尿病患者的生存和血糖控制

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Aim: The impact of diabetes mellitus (DM) on survival in patients with colorectal cancer and the impact of colorectal cancer on glycemic control were examined. Materials & methods: Patients with colorectal cancer with and without DM were matched 1:1 (2007–2015). Characteristics were compared between the two groups and survival assessed with the Kaplan–Meier method. Mixed models compared hemoglobin A1c and glucose levels over time. Results: In both groups, glucose values decreased during the year following cancer diagnosis (p < 0.001). 5-year overall survival was 56% (95% CI: 42–68%) for DM patients versus 57% (95% CI: 43–69%) for non-DM patients (p = 0.62). Conclusion: DM did not adversely impact survival of patients with colorectal cancer. Colorectal cancer did not affect glycemic control.
机译:目的:研究了糖尿病(DM)对结直肠癌患者生存的影响以及结直肠癌对血糖控制的影响。材料与方法:患有和不患有DM的结直肠癌患者均按1:1(2007-2015)进行匹配。比较两组之间的特征,并通过Kaplan-Meier方法评估生存率。混合模型比较了一段时间内的血红蛋白A1c和葡萄糖水平。结果:两组在癌症诊断后的一年中葡萄糖值均下降(p <0.001)。 DM患者的5年总生存率为56%(95%CI:42–68%),而非DM患者为57%(95%CI:43–69%)(p = 0.62)。结论:DM对大肠癌患者的生存没有不利影响。大肠癌不影响血糖控制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号